XtalPi Leverages AWS to Enhance Drug Discovery

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to XtalPi Leverages AWS to Enhance Drug Discovery

BofA on Amazon.com (AMZN): 'Remain constructive on AWS revenue acceleration in '25'

December 4, 2024 9:33 AM EST

BofA Securities analyst Justin Post reiterated a Buy rating and $230.00 price target on Amazon.com (NASDAQ: AMZN).

The analyst comments "Remain constructive on AWS revenue acceleration in '25. We see potential for AWS revenue acceleration in '25 from greater Nvidia & Tranium2 availability for... More